How were biosimilars discussed at ESMO 2017?

(1:1econd)

ESMO 2017: Melanoma highlights | Olivier Michielin

(4:2)

ESMO 2017 highlights on managing difficult to treat cancers

(17:52)

ESMO 2017 - Iain McNeish

(7:37)

ESMO 2017: Prostate cancer highlights

(19:48)

Genitourinary cancer highlights from ESMO 2017 | Rodrigo Dienstmann

(6:54)

Pancrease Disease | പാന്‍ക്രിയാസിനെ ബാധിക്കുന്ന അസുഖങ്ങള്‍ | 22 Dec 2016

(21:28)

Basis for immunotherapy in lung cancer

(22:9)

BRCA2, Prostate Cancer + Lynparza

(10:15)

ASCO 2022 | Pr René Adam : Métastases hépatiques cancer du sein et cancer colorectal

(4:43)

Metastatic breast cancer at ESMO 2022: TROPiCS02, MONARCH 3 and SYNERGY

(5:37)

Dr. Mohamad Jahanzeb's talk on Breast Cancer_August 28 2015_Binaytara Foundation

(46:7)

ESMO Breast Cancer 2025 - Submit your abstract

(2:)

ESMO 2017: CDK4/6 inhibitors from a patient’s perspective

(30:52)

Cervical Cancer Screening Guidelines Update

(18:35)

FLAURA study: a new standard of care for patients with EGFR mutated NSCLC

(6:8)

ESMO 2017 - PALBONET Trial - Dr. Enrique Grande

(1:46)

LuCE at ESMO 2017 – Lung cancer highlights and Access to treatment

(11:46)

ESMO 2017 - Presidential Symposium Lung Cancer Dr Mohammad Jahanzeb

(6:1econd)

ESMO 2017: RANGE trial results | Daniel Petrylak

(2:5)

Interesting topics presented at ESMO 2017

(3:24)

ESMO 2017 - Joe O'Sullivan Interview

(5:54)

Highlights of the ESMO 2017 lung cancer program | Lecia Sequist

(6:24)

Important topics at ESMO 2017

(3:52)

ESMO 2017 - Sharlene Gill Interview

(5:2)

ESMO 2017: An Overview of the Treatment Landscape for Locally-Advanced, Unresectable NSCLC

(4:8)

ESMO 2017: BRIM8 trial findings | Karl Lewis

(2:58)

ESMO 2017 Highlights - Dr. Luiz Alberto Matos

(3:15)

ESMO 2017 - Frédérique Penault Llorca

(2:21)

NSCLC highlights from ESMO 2017 | Floriana Morgillo

(5:11)